Free shipping above 75,00€ For domestic delivery

Bioactive metabolites isolated from Hericium erinaceus (Bull.) Pers.

Studies
Author/s: Asst.Prof. Andrej Gregori, PhD, Jovana Ljujić, Dejan Stojković, Katarina Simić, Stefan Ivanović, Antoaneta Trendafilova, Boban Anđelković, Ivana Sofrenić
Publish date: 14.05.2026

Hericium erinaceus is considered one of the most promising medicinal fungi for the treatment of neurodegenerative diseases, containing a wide variety of bioactive compounds, including hericenones, erinacines, and many other related molecules, which exhibit significant neurotrophic and neuroprotective properties.

Previous studies demonstrated that erinacine enriched mycelium of H. erinaceus can delay neuronal cell death in animal models of neurodegenerative conditions such as Alzheimer’s disease and ischemic stroke.

Research was funded by

Our research focus on the isolation of a diverse range of bioactive compounds from employing conventional crhomatographic techniques, followed by their structural characterization predominantly through nuclear magnetic resonance (NMR) spectroscopy. Hericene A was isolated from the ethyl acetate extract of the H. erinaceus fruiting bodies by performing gravitational chromatography, followed by additional purification on semi-dry flash chromatography.

Furthermore, erinacines A and C were isolated from the ethyl acetate extract of the mycelium. The extract was initially processed through semi-dry flash chromatography, followed by subsequent purification utilizing preparative high-performance liquid chromatography (HPLC).

The structures of isolated compounds were determined using 1D (¹H NMR and 13C) and 2D (COSY, JRES, HMBC, HSQC and NOESY) NMR experiments. These purification methodologies demonstrated high efficiency and cost-effectiveness, resulting in the isolation of pure natural compounds appropriate for subsequent pharmacological investigations.

Future investigations will prioritize the optimization of isolation protocols for various metabolites derived from both the mycelium and fruiting bodies of H. erinaceus, alongside comprehensive characterization and systematic evaluation of their biological activities, with the aim of elucidating potential therapeutic applications in the treatment of neurodegenerative disorders, particularly Alzheimer’s disease.

In collaboration with:

Moj račun
Košarica

No products in the cart.

Treat yourself to a 5% discount for a mushroom dose of well-being and join the GOBA community!

For those who don’t just want quick fixes, but lasting balance. For those who understand that health is not a goal, but a way of life. For those who aren’t just looking for a nutritional supplement, but a companion on the path to well-being. Because sometimes the smallest things bring the biggest changes. A 5% discount awaits you on your first purchase – as a small thank you for your trust.